Patterns of response to anti-PD1 treatment: Comparison of three radiological response criteria and effect on overall survival (OS) in metastatic melanoma patients (MM)

被引:0
|
作者
Kibiro, Minnie
Khoja, Leila
Hogg, David
Butler, Marcus O.
Metser, Ur
Atenafu, Eshetu G.
Joshua, Anthony M.
机构
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9073
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study
    Herbreteau, Guillaume
    Vallee, Audrey
    Knol, Anne-Chantal
    Theoleyre, Sandrine
    Quereux, Gaelle
    Varey, Emilie
    Khammari, Amir
    Dreno, Brigitte
    Denis, Marc G.
    CANCERS, 2021, 13 (08)
  • [42] Spleen to liver ratio (SLR): Novel PET imaging biomarker for prediction of overall survival after ipilimumab and anti-PD1 in patients with metastatic melanoma.
    Wong, Annie Ngai Man
    Callahan, Jason
    Beresford, Jenny
    Herschtal, Alan
    Fullerton, Sonia
    Miine, Donna
    Hicks, Rodney J.
    McArthur, Grant A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy
    Amato, Carol M.
    Hintzsche, Jennifer D.
    Wells, Keith
    Applegate, Allison
    Gorden, Nicholas T.
    Vorwald, Victoria M.
    Tobin, Richard P.
    Nassar, Kelsey
    Shellman, Yiqun G.
    Kim, Jihye
    Medina, Theresa M.
    Rioth, Matthew
    Lewis, Karl D.
    McCarter, Martin D.
    Gonzalez, Rene
    Tan, Aik-Choon
    Robinson, William A.
    CANCERS, 2020, 12 (07) : 1 - 15
  • [44] Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma
    Serrati, Simona
    Di Fonte, Roberta
    Porcelli, Letizia
    De Summa, Simona
    De Risi, Ivana
    Fucci, Livia
    Ruggieri, Eustachio
    Marvulli, Tommaso Maria
    Strippoli, Sabino
    Fasano, Rossella
    Rafaschieri, Tania
    Guida, Gabriella
    Guida, Michele
    Azzariti, Amalia
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [45] Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma
    Simona Serratì
    Roberta Di Fonte
    Letizia Porcelli
    Simona De Summa
    Ivana De Risi
    Livia Fucci
    Eustachio Ruggieri
    Tommaso Maria Marvulli
    Sabino Strippoli
    Rossella Fasano
    Tania Rafaschieri
    Gabriella Guida
    Michele Guida
    Amalia Azzariti
    Journal of Experimental & Clinical Cancer Research, 42
  • [46] Predict progression free survival and overall survival using objective response rate for anti-PD1/PDL1 therapy development
    Yang, Lei
    Raveendran, Geethanjali
    Meng, Xiang
    Lin, Ji
    Meng, Zhaoling
    BMC CANCER, 2024, 24 (01)
  • [47] Single-cell roadmap of the evolution of T-cell response during anti-LAG3 and anti-PD1 combination treatment in metastatic melanoma patients
    Huuhtanen, Jani
    Hakanen, Henna H. E.
    Lonnberg, Tapio
    Dufva, Olli
    Peltola, Katriina
    Makela, Siru
    Hernberg, Micaela
    Bono, Petri
    Anna, Kreutzman
    Mustjoki, Satu
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [48] Off treatment survival (OTS) in patients (pts) with advanced melanoma after anti-PD1 therapy.
    Christiansen, Shelly Ann
    Swoboda, David
    Gardner, Kellie
    Rapisuwon, Suthee
    Atkins, Michael B.
    Gibney, Geoffrey Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] Baseline clinical and imaging predictors of treatment response and overall survival of patients with metastatic melanoma undergoing immunotherapy
    Schraag, Amadeus
    Klumpp, Bernhard
    Afat, Saif
    Gatidis, Sergios
    Nikolaou, Konstantin
    Eigentler, Thomas K.
    Othman, Ahmed E.
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 121
  • [50] Complete response of metastatic melanoma in a patient with Crohn's disease simultaneously receiving anti-47 and anti-PD1 antibodies
    Frohne, Christopher C.
    Llano, Ernesto M.
    Perkovic, Ashley
    Cohen, Russell D.
    Luke, Jason J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7